Malin Corporation | MLC - Loan Capital


Malin Corporation reported EUR0 in Loan Capital for its fiscal semester ending in December of 2024.





Loan Capital Change Date
Akebia Therapeutics USD 24.75M 11.64M Jun/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
ALKERMES USD 1.48B 7.23M Jun/2026
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Eurofins Scientific SE EUR 3.7B 5M Jun/2026
Ionis Pharmaceuticals USD 1.91B 6.62M Jun/2026
IQVIA Holdings USD 13.7B 284M Jun/2026
Lonza CHF 3.88B 323M Dec/2025
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 597M 6M Jun/2026
Organon & Co USD 8.55B 75M Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Revvity USD 2.63B 1.02M Jun/2026
Tectonic Therapeutic USD 17K 26K Mar/2026
Viatris USD 11.61B 801.1M Jun/2026
Xeris Pharmaceuticals USD 188.81M 32.42M Jun/2026